Clinical Laboratory
|
Service |
Unit of Measurement |
Rate, VAT is not included, BYN |
Cost of Consumables |
Total Price | |||
|---|---|---|---|---|---|---|---|
|
1 |
|
2 |
|
3 |
4 |
5 |
6 |
|
|
Clinical Laboratory |
||||||
|
|
Pipetting |
||||||
|
1. 2. |
Registration (initial and final) of materials, patient’s passport details and test results in worksheets or databases |
test |
2.53 |
0.20 |
2.73 |
||
|
|
Tests |
||||||
|
|
Standard coagulation profile (clauses 1.2. + 1.4.1. + 1.5. + 6.40.1. + 6.40.2. + 6.40.3. + 6.6.4.) |
test |
12.44 |
14.41 |
26.85 |
||
|
|
Stool test (clauses 1.2. + 2.8.1. + 2.8.2. + 2.8.3.) |
test |
15.48 |
4.61 |
20.09 |
||
|
|
Complete blood count + reticulocyte count (clauses 1.2.+ 1.4.+ 3.7.+ 3.9.1.+ 3.26.3. + 3.4.) |
test |
25.78 |
4.73 |
30.51 |
||
|
|
Complete blood count + platelets (clauses 1.2.+ 1.3.2.+ 3.7.+ 3.9.1.+ 3.26.3. + 3.6.1.) |
test |
28.05 |
3.13 |
31.18 |
||
|
|
Complete blood count (clauses 1.2.+ 1.4..+ 3.7.+ 3.9.1.+ 3.26.3.) |
test |
17.91 |
2.62 |
20.53 |
||
|
|
Urinalysis (clauses 1. 2. + 2. 1. 9. + 2. 1. 4. 1. + 2. 1.10. 1.) |
test |
10.12 |
0.95 |
11.07 |
||
|
|
Test for blood group and rhesus factor in accordance with ABO system (cross-reaction) (clauses 1.2. + 1.4.2. + 1.5.+ 7.2.) |
test |
14.45 |
7.06 |
21.51 |
||
|
|
Rehberg test (clauses 1.2. + 1.4. + 1.5. + (5.13.3.1.3.) х 2) |
test |
8.81 |
1.09 |
9.90 |
||
|
|
Syphilis test (RPR-carbon) (clauses 1.2.+ 1.4.3.+ 1.5.+ 8.17.9.1.11) |
test |
19.06 |
0.25 |
19.31 |
||
|
1. |
Single procedure |
||||||
|
1. 1. 2. |
Pipetting with a semi-automated pipettor |
pipetting |
0.12 |
0.02 |
0.14 |
||
|
1. 1. 3. |
Pipetting with an automated pipettor |
pipetting |
0.05 |
0.01 |
0.06 |
||
|
1.3. |
Capillary blood sampling |
||||||
|
1. 3. 1. |
Capillary blood sampling for hematological tests (one score), blood chemistry (peripheral blood glucose, rapid INR test, malaria test) |
test |
0.13 |
0.53 |
0.66 |
||
|
1. 3. 2. |
Capillary blood sampling for a full range of hematological tests within a complete blood count, including white blood cell count |
test |
2.25 |
0.73 |
2.98 |
||
|
1.4. |
Venous blood sampling |
||||||
|
1. 4. |
Venous blood sampling (blood chemistry) |
test |
2.44 |
0.99 |
3.43 |
||
|
1. 4. 1. |
Venous blood sampling (coagulation profile, INR and single coagulation parameters) |
test |
2.44 |
1.05 |
3.49 |
||
|
1. 4. 2. |
Venous blood sampling (blood group, rhesus factor, antibodies) |
test |
2.44 |
1.06 |
3.50 |
||
|
1. 4. 3. |
Venous blood sampling (immunochemistry, hormones, tumor markers, ELISA (Chlamydia, APAS, tests for autoimmune diseases)) |
test |
2.44 |
0.92 |
3.36 |
||
|
1. 4. 4. |
Venous blood sampling (glycosylated hemoglobin, cardiac triad) |
test |
2.44 |
0.92 |
3.36 |
||
|
1. 5. |
Venous blood processing to obtain plasma and serum |
test |
1.68 |
0.01 |
1.69 |
||
|
2.1. |
Urine tests |
||||||
|
2. 1. 2. |
Rapid test for glucose in urine |
test |
1.40 |
0.58 |
1.98 |
||
|
2. 1. 3. 1. |
Rapid test for protein in urine |
test |
1.40 |
0.58 |
1.98 |
||
|
2. 1. 4. 1. |
Test for protein and sulfoacetic in urine |
test |
3.66 |
0.14 |
3.80 |
||
|
2. 1. 6. |
Rapid test for urine ketones |
test |
1.40 |
0.58 |
1.98 |
||
|
2. 1. 7. |
Rapid test for bilirubin in urine |
test |
1.40 |
0.58 |
1.98 |
||
|
2. 1. 8. |
Rapid test for urobilin in urine |
test |
1.40 |
0.58 |
1.98 |
||
|
2. 1. 9. |
Testing of a range of parameters within the complete blood count with the help of semi-automated dry chemistry analyzers Testing of a range of parameters within urinalysis with the help of semi-automated dry chemistry analyzers |
test |
1.68 |
0.77 |
2.45 |
||
|
2. 1.10. 1. |
Microscopic examination of urine sediment |
examination |
2.25 |
0.03 |
2.28 |
||
|
2. 1.11. |
Count of formed elements in urine according to Nechiporenko (Nechiporenko urine test) |
test |
8.17 |
0.04 |
8.21 |
||
|
2. 1.12. |
Test for renal coting ability according to Zimnitsky |
test |
5.64 |
0.01 |
5.65 |
||
|
2.10. |
Test for trichomonas and gonococci in urethral and vaginal samples, stained by methyl blue (Gram staining) |
||||||
|
2.10. 1. |
Test for trichomonas and gonococci in urethral and vaginal samples, stained by methyl blue (culture swab from one focus) |
test |
9.73 |
0.02 |
9.75 |
||
|
2.10. 2. |
Test for trichomonas and gonococci in urethral and vaginal samples, stained according to Gram (culture swab from one focus) |
test |
12.71 |
0.03 |
12.74 |
||
|
2.2. |
Cerebrospinal fluid examination |
||||||
|
2. 2. 1. |
Examination of colour, clearance, relative density, fibrous coat in cerebrospinal fluid |
examination |
1.68 |
0.01 |
1.69 |
||
|
2. 2. 2. |
Test for protein in cerebrospinal fluid (Pandy’s test) |
test |
1.40 |
0.03 |
1.43 |
||
|
2. 2. 3. 1. |
Test for protein and sulfoacetic in cerebrospinal fluid |
test |
3.38 |
0.03 |
3.41 |
||
|
2. 2. 4. |
Count of cell elements (cytosis) and differential count of cell elements in cerebrospinal fluid in a native preparation |
test |
10.85 |
0.13 |
10.98 |
||
|
2. 2. 5. |
Microscopic examination of cerebrospinal fluid in a stained preparation |
examination |
8.51 |
0.60 |
9.11 |
||
|
2.3. |
Examination of exudates and transudates |
||||||
|
2. 3. 1. |
Examination of quantity, pattern, clearance and relative density of exudates and transudates |
examination |
1.13 |
0.12 |
1.25 |
||
|
2. 3. 2. |
Rivalta’s test for protein in exudates and transudates |
test |
2.25 |
0.21 |
2.46 |
||
|
2. 3. 3. |
Microscopic examination of exudates and transudates |
examination |
17.46 |
0.60 |
18.06 |
||
|
2.4. |
Examination of sputum |
||||||
|
2. 4. 1. |
Examination of quantity, pattern, colour, consistency and odor of sputum |
examination |
1.13 |
0.45 |
1.58 |
||
|
2. 4. 2. 1. |
Microscopic examination of sputum in a native preparation |
examination |
4.79 |
0.27 |
5.06 |
||
|
2. 4. 2. 2. |
Microscopic examination of sputum in a stained preparation |
examination |
5.64 |
0.51 |
6.15 |
||
|
2. 4. 3. 2. |
Microscopic examination for acid-fast bacteria in the preparations stained according to Zhiel-Neelsen (quantitative method, per 100 fields of vision) |
examination |
12.41 |
0.61 |
13.02 |
||
|
2.7. |
Examination of synovial fluid |
||||||
|
2. 7. 1. |
Examination of physical and chemical properties of synovial fluid |
examination |
2.25 |
0.99 |
3.24 |
||
|
2. 7. 2. |
Cell element count (cytosis) and differential count of cell elements in synovial fluid in a native preparation |
examination |
8.72 |
0.08 |
8.80 |
||
|
2. 7. 3. |
Microscopic examination of synovial fluid in a stained preparation |
examination |
6.76 |
0.58 |
7.34 |
||
|
2.8. |
Stool test |
||||||
|
2. 8. 1. |
Examination of colour, consistency, odor, admixtures, mucus and pH in stool |
examination |
1.13 |
0.04 |
1.17 |
||
|
2. 8. 2. |
Examination for blood in stool (antibodies to НB) |
examination |
1.68 |
3.80 |
5.48 |
||
|
2. 8. 3. |
Microscopic examination of stool (in 3 preparations) |
examination |
10.14 |
0.75 |
10.89 |
||
|
2. 8. 4. 1. |
Stool test for parasite eggs (cryptosporidias) |
test |
4.51 |
4.55 |
9.06 |
||
|
2. 8. 4. 2. |
Stool test for parasite eggs (lamblias) |
test |
4.51 |
5.19 |
9.70 |
||
|
2. 8. 5. |
Stool test for helminth eggs in 1 preparation (Kato technique) |
test |
6.19 |
0.31 |
6.50 |
||
|
2.9. |
Stool test for enteribiasis |
||||||
|
2. 9. 1. |
Scraping for enterobiasis (in 3 preparations) |
test |
6.19 |
0.04 |
6.23 |
||
|
3. |
Hematology tests |
||||||
|
3. 4. |
Reticulocyte count |
test |
7.87 |
2.11 |
9.98 |
||
|
3. 5. |
Red blood cell count + basophilic stripping |
test |
9.02 |
0.51 |
9.53 |
||
|
3. 6. 1. |
Platelet count in stained smears (according to Fonio) |
test |
10.14 |
0.51 |
10.65 |
||
|
3. 7. |
Erythrocyte sedimentation rate (ESR) |
test |
1.13 |
0.30 |
1.43 |
||
|
3. 9. 1. |
White blood cell count + description of blood cell morphology for non-hematological diseases |
test |
3.94 |
0.51 |
4.45 |
||
|
3.13. |
LE-cell count according to Novoselova |
test |
35.45 |
1.39 |
36.84 |
||
|
3.14. 1. |
Test for malaria parasites + preparation of a thick blood film |
test |
14.17 |
1.14 |
15.31 |
||
|
3.14. 2. |
Test for malaria parasites in a stained smear |
test |
12.06 |
1.14 |
13.20 |
||
|
3.26. 3. |
Blood tests carried out with the help of automated hematology analyzers (+ white blood cell differentiation) |
test |
7.87 |
0.81 |
8.68 |
||
|
5.10.1. |
Dry chemistry tests for cardiac markers |
||||||
|
5.10. 1. 2. |
Troponin, myoglobin, creatine kinase-MB |
test |
19.16 |
28.77 |
47.93 |
||
|
5.10.2. |
Immunoassay for cardiac markers |
||||||
|
5.10. 2. 1. |
High-sensitive troponin in venous blood |
assay |
19.14 |
8.65 |
27.79 |
||
|
5.10. 2. 2. |
Myoblobin in venous blood |
assay |
19.14 |
8.71 |
27.85 |
||
|
5.10. 2. 3. |
Creatine kinase-MB in venous blood (mass concentration) |
assay |
19.14 |
6.37 |
25.51 |
||
|
5.10. 2. 4. |
BNP (brain natriuretic peptide) in venous blood |
assay |
19.14 |
18.95 |
38.09 |
||
|
5.10. 2. 5. |
NT- proBNP (N-terminal probrain natriuretic peptide) in venous blood |
assay |
19.14 |
20.35 |
39.49 |
||
|
5.11.2. |
Enzyme-linked immunosorbent assays (ELISA) for tumor markers (ELISA) |
||||||
|
5.11. 2. 1. |
Alfa-fetoprotein ELISA |
assay |
11.27 |
7.99 |
19.26 |
||
|
5.11. 2. 2. |
Carcinoembryonic antigen ELISA |
assay |
11.27 |
7.99 |
19.26 |
||
|
5.11. 2. 3. |
СА 19-9 ELISA |
assay |
11.27 |
9.14 |
20.41 |
||
|
5.11. 2. 4. |
СА – 125 ELISA |
assay |
11.27 |
8.94 |
20.21 |
||
|
5.11. 2. 5. |
СА 15- 3 |
assay |
11.27 |
8.96 |
20.23 |
||
|
5.11. 2. 6. |
Total prostate-specific antigen (PSA) ELISA |
assay |
11.27 |
8.83 |
20.10 |
||
|
5.11. 2. 7. |
Free prostate-specific antigen (free PSA) ELISA |
assay |
11.27 |
9.14 |
20.41 |
||
|
5.11. 2. 8. |
В-2-microglobulin ELISA |
assay |
11.27 |
7.95 |
19.22 |
||
|
5.11. 2. 9. |
СА 242 ELISA |
assay |
11.27 |
13.17 |
24.44 |
||
|
5.11. 2.10. |
Cyfra 21-1 ELISA |
assay |
11.27 |
17.21 |
28.48 |
||
|
5.11. 2.11. |
HE-4 ELISA |
assay |
11.27 |
27.32 |
38.59 |
||
|
5.13.3.1. |
Assays carried out with the help of multi-channel automated biochemistry analyzers (non-automated registration of results) |
||||||
|
5.13. 1. 1. 1. |
Glycosylated hemoglobin (Hb A1) (concentration) |
assay |
1.08 |
6.45 |
7.53 |
||
|
5.13. 3. 1. 1 |
Total protein (blood chemistry) |
assay |
1.08 |
0.04 |
1.12 |
||
|
5.13. 3. 1. 2. |
Albumin (blood chemistry) |
assay |
1.08 |
0.06 |
1.14 |
||
|
5.13. 3. 1. 3. |
Creatinine (blood chemistry) |
assay |
1.08 |
0.04 |
1.12 |
||
|
5.13. 3. 1. 4. |
Urea (blood chemistry) |
assay |
1.08 |
0.09 |
1.17 |
||
|
5.13. 3. 1. 5. |
Uric acid (blood chemistry) |
assay |
1.08 |
0.14 |
1.22 |
||
|
5.13. 3. 1. 6. |
Total cholesterol (blood chemistry) |
assay |
1.08 |
0.10 |
1.18 |
||
|
5.13. 3. 1. 7. |
High density lipoprotein cholesterol (HDL) (Blood chemistry) |
assay |
1.08 |
0.44 |
1.52 |
||
|
5.13. 3. 1. 8. |
Low density lipoprotein cholesterol (LDL) (Blood chemistry) |
assay |
1.08 |
1.25 |
2.33 |
||
|
5.13. 3. 1. 9. |
Serum glucose (blood chemistry) |
assay |
1.08 |
0.07 |
1.15 |
||
|
5.13. 3. 1.10. |
Total bilirubin (blood chemistry) |
assay |
1.08 |
0.10 |
1.18 |
||
|
5.13. 3. 1.11. |
Direct bilirubin (blood chemistry) |
assay |
1.08 |
0.16 |
1.24 |
||
|
5.13. 3. 1.13. |
Calcium (blood chemistry) |
assay |
1.08 |
0.08 |
1.16 |
||
|
5.13. 3. 1.14 |
Potassium (blood chemistry) |
assay |
1.08 |
0.69 |
1.77 |
||
|
5.13. 3. 1.15 |
Sodium (blood chemistry) |
assay |
1.08 |
0.69 |
1.77 |
||
|
5.13. 3. 1.16 |
Chlorides (blood chemistry) |
assay |
1.08 |
0.69 |
1.77 |
||
|
5.13. 3. 1.17 |
Inorganic phosphorus (blood chemistry) |
assay |
1.08 |
0.06 |
1.14 |
||
|
5.13. 3. 1.18 |
Alanine aminotransferase (ALT) (blood chemistry) |
assay |
1.08 |
0.03 |
1.11 |
||
|
5.13. 3. 1.19 |
Alanine aminotransferase (ALT) (blood chemistry) |
assay |
1.08 |
0.07 |
1.15 |
||
|
5.13. 3. 1.20 |
A-Amylase in serum (blood chemistry) |
assay |
1.08 |
0.29 |
1.37 |
||
|
5.13. 3. 1.21 |
A-Amylase (diastase) in urine (blood chemistry) |
assay |
1.08 |
0.13 |
1.21 |
||
|
5.13. 3. 1.22 |
Pancriatic amylase (blood chemistry) |
assay |
1.08 |
0.79 |
1.87 |
||
|
5.13. 3. 1.23 |
Lipase |
assay |
1.08 |
1.30 |
2.38 |
||
|
5.13. 3. 1.24 |
Acid phosphatase (activity) (blood chemistry) |
assay |
1.08 |
0.06 |
1.14 |
||
|
5.13. 3. 1.25 |
Gamma-glutamyltransferase (GGT) (activity) (blood chemistry) |
assay |
1.08 |
0.12 |
1.20 |
||
|
5.13. 3. 1.26 |
HBDH (activity) (blood chemistry) |
assay |
1.08 |
0.06 |
1.14 |
||
|
5.13. 3. 1.27 |
Lactate dehydrogenase (LDH) (activity) (blood chemistry) |
assay |
1.08 |
0.06 |
1.14 |
||
|
5.13. 3. 1.28 |
Creatine kinase (activity) (blood chemistry) |
assay |
1.08 |
0.39 |
1.47 |
||
|
5.13. 3. 1.29 |
CK-MB (activity) (blood chemistry) |
assay |
1.08 |
1.32 |
2.40 |
||
|
5.13. 3. 1.30 |
Serum iron (level) (blood chemistry) |
assay |
1.08 |
0.11 |
1.19 |
||
|
5.13. 3. 1.31 |
Triglycerides (blood chemistry) |
assay |
1.08 |
0.18 |
1.26 |
||
|
5.13. 3. 1.32 |
Ferritin (blood chemistry) |
assay |
1.08 |
2.06 |
3.14 |
||
|
5.13. 3. 1.33 |
Transferrin (blood chemistry) |
assay |
1.08 |
1.00 |
2.08 |
||
|
5.13. 3. 1.34 |
Myoglobin (blood chemistry) |
assay |
1.08 |
2.49 |
3.57 |
||
|
5.13. 3. 1.35 |
Microalbumin in urine |
assay |
1.08 |
0.53 |
1.61 |
||
|
5.13. 3. 1.36 |
Magnesium (blood chemistry) |
assay |
1.08 |
0.07 |
1.15 |
||
|
5.13. 3. 1.37 |
Apoprotein A1 (blood chemistry) |
assay |
1.08 |
0.46 |
1.54 |
||
|
5.13. 3. 1.38 |
Apoprotein B (blood chemistry) |
assay |
1.08 |
0.46 |
1.54 |
||
|
5.13. 3. 1.41 |
Copper (blood chemistry) |
assay |
1.08 |
0.25 |
1.33 |
||
|
5.13. 3. 1.42 |
Alpha‑1‑antitrypsin (blood chemistry) |
assay |
1.08 |
1.47 |
2.55 |
||
|
5.13. 3. 1.43 |
Ceruloplasmin (blood chemistry) |
assay |
1.08 |
0.84 |
1.92 |
||
|
5.13. 3. 1.44. |
Glucose (glucose tolerance test), double |
assay |
1.08 |
1.69 |
2.77 |
||
|
5.13. 3. 1.46 |
Fructosamine |
assay |
1.08 |
0.18 |
1.26 |
||
|
5.13. 3. 1.47 |
Cystatin С |
assay |
1.08 |
1.35 |
2.43 |
||
|
5.13. 3. 1.48 |
Homocysteine |
assay |
1.08 |
1.55 |
2.63 |
||
|
5.13. 3. 1.49 |
Cholinesterase |
assay |
1.08 |
0.40 |
1.48 |
||
|
5.13. 3. 1.50 |
Total iron binding capacity (TIBC) |
assay |
1.08 |
1.63 |
2.71 |
||
|
5.13. 3. 1.51 |
Haptoglobin |
assay |
1.08 |
3.54 |
4.62 |
||
|
5.2. |
Biochemistry tests carried out with the help of photoelectric colorimeters and single-channel automated photometers |
||||||
|
5. 2. 7. |
Rapid test for glucose in whole blood |
test |
4.18 |
1.44 |
5.62 |
||
|
5.6. |
Biochemistry tests for acid-base balance carried out with the help of automated analyzers |
||||||
|
5. 6. |
Evaluation of acid-base balance |
test |
3.91 |
18.97 |
22.88 |
||
|
5. 6. 1. |
Evaluation of acid-base balance with the help of automated analyzers |
test |
3.91 |
18.99 |
22.90 |
||
|
5.8. |
Electrophoretis assays of serum using cellulose acetate films and agarose gels |
||||||
|
5. 8. 1. |
Electrophoretis assays of serum using cellulose acetate films and agarose gels (protein fractions, protein electrophoresis) |
assay |
23.98 |
0.90 |
24.88 |
||
|
5.9.1. |
Enzyme-linked immunosorbent assays (ELISA) for hormones |
||||||
|
5. 9. 1. 1. 1 |
E ELISA, estradiol (sex hormone) |
assay |
4.37 |
6.31 |
10.68 |
||
|
5. 9. 1. 1. 2 |
FSH ELISA, follicle-stimulating hormone (sex hormone) |
assay |
4.37 |
6.31 |
10.68 |
||
|
5. 9. 1. 1. 3 |
LH ELISA, luteinizing hormone (sex hormone) |
assay |
4.37 |
6.31 |
10.68 |
||
|
5. 9. 1. 1. 4. |
P4 ELISA, progesterone (sex hormone) |
assay |
4.37 |
6.31 |
10.68 |
||
|
5. 9. 1. 1. 5 |
PRL ELISA, prolactin (sex hormone) |
assay |
4.37 |
7.84 |
12.21 |
||
|
5. 9. 1. 1. 6. |
T ELISA, testosterone (sex hormone) |
assay |
4.37 |
6.15 |
10.52 |
||
|
5. 9. 1. 1. 7. |
hCG or beta-hCG ELISA, human chorionic gonadotropin or human beta-chorionic gonadotropin (sex hormone) |
assay |
4.37 |
8.38 |
12.75 |
||
|
5. 9. 1. 1. 8. |
TSH ELISA, thyroid-stimulating hormone (thyroid hormone) |
assay |
4.37 |
5.15 |
9.52 |
||
|
5. 9. 1. 1. 9. |
FT4 ELISA, free thyroxin (thyroid hormone) |
assay |
4.37 |
4.35 |
8.72 |
||
|
5. 9. 1. 1.10. |
FT3 ELISA, free triiodothyronine (thyroid hormone) |
assay |
4.37 |
3.91 |
8.28 |
||
|
5. 9. 1. 1.11. |
PCT ELISA, procalcitonin (other hormones) |
assay |
4.37 |
21.55 |
25.92 |
||
|
5. 9. 1. 1.12. |
COR ELISA, cortisol (other hormones) |
assay |
4.37 |
7.21 |
11.58 |
||
|
5. 9. 1. 1.13. |
TgAb ELISA, thyroglobulin antibodies (thyroid hormone) |
assay |
4.37 |
9.28 |
13.65 |
||
|
5. 9. 1. 1.14. |
DHEA-S ELISA, dehydroepiandrosterone sulfate |
assay |
4.37 |
5.36 |
9.73 |
||
|
5. 9. 1. 1.15. |
17-OHP ELISA, 17-hydroxyprogesterone |
assay |
4.37 |
6.85 |
11.22 |
||
|
5. 9. 1. 2. 2. |
TPOAb ELISA, thyroid peroxidase antibodies (thyroid hormone) |
assay |
5.40 |
10.63 |
16.03 |
||
|
6. |
Tests of Hemostasis |
||||||
|
6. 6. 4. |
Test for fibrinogen in plasma using a coagulation analyzer |
test |
1.44 |
4.61 |
6.05 |
||
|
6.31. |
Blood clotting test for lupus anticoagulant |
test |
30.48 |
14.79 |
45.27 |
||
|
6.34. |
Antithrombin III (АТ III) test |
test |
17.72 |
12.08 |
29.80 |
||
|
6.37. |
C-reactive protein test using a coagulation analyzer |
test |
17.72 |
10.69 |
28.41 |
||
|
6.39. |
D-dimers test |
test |
17.72 |
12.69 |
30.41 |
||
|
6.39. 1. |
Rapid test for D-dimers (immunofluorescence technique) |
test |
17.72 |
15.12 |
32.84 |
||
|
6.40. 1. |
Test for activated partial thromboplastin time (PTT) using a coagulation analyzer |
test |
1.45 |
2.70 |
4.15 |
||
|
6.40. 2. |
Prothrombin time test (PT) using calcium thromboplastin mixture + measurement of the INR |
test |
1.45 |
2.98 |
4.43 |
||
|
6.40. 2. 1. |
Prothrombin time test (PT) using calcium + measurement of the INR (rapid test using capillary blood) |
test |
1.45 |
7.12 |
8.57 |
||
|
6.40. 3. |
Thrombin time test (ТВ) |
test |
1.45 |
3.05 |
4.50 |
||
|
7. |
Immunology Tests |
||||||
|
7. 2. |
Test for blood group and rhesus factor in accordance with ABO system (cross-reaction) |
test |
7.80 |
6.04 |
13.84 |
||
|
7. 4. |
Conglutination test for incomplete rhesus-antibodies |
test |
24.81 |
1.69 |
26.50 |
||
|
7. 5. |
Conglutination test for incomplete antibody titer |
test |
28.35 |
9.07 |
37.42 |
||
|
7. 6. |
Direct Coombs test |
test |
28.35 |
1.85 |
30.20 |
||
|
7. 7. |
Indirect Coombs test |
test |
49.62 |
4.47 |
54.09 |
||
|
7.16. 2. 1. |
Total CRP (turbidimetric test for individual serum proteins) |
test |
2.55 |
0.70 |
3.25 |
||
|
7.16. 2. 2. |
High-sensitive CRP (turbidimetric test for individual serum proteins) |
test |
2.55 |
0.91 |
3.46 |
||
|
7.16. 2. 3 |
IgА |
test |
2.55 |
2.05 |
4.60 |
||
|
7.16. 2. 4 |
IgМ |
test |
2.55 |
2.25 |
4.80 |
||
|
7.16. 2. 5 |
IgG |
test |
2.55 |
2.25 |
4.80 |
||
|
7.17. 2. |
Latex test for the activity of anti-streptolysin O in serum |
test |
1.68 |
1.39 |
3.07 |
||
|
7.19. 2. 1. 1. |
Anti-cardiolipin M antibodies ELISA (IgM), semi-automated calculation |
assay |
4.37 |
11.56 |
15.93 |
||
|
7.19. 2. 1. 2. |
Anti-cardiolipin G antibodies ELISA (IgG) semi-automated calculation |
assay |
4.37 |
11.56 |
15.93 |
||
|
7.19. 2. 1. 3. |
Anti-β2-glycoprotein M antibodies ELISA (IgM), semi-automated calculation |
assay |
4.37 |
11.56 |
15.93 |
||
|
7.19. 2. 1. 4. |
Anti-β2-glycoprotein G antibodies ELISA (IgG), semi-automated calculation |
assay |
4.37 |
11.56 |
15.93 |
||
|
7.19. 2. 1. 5. |
Anti-nucleosome antibodies ELISA, semi-automated calculation |
assay |
4.37 |
11.56 |
15.93 |
||
|
7.19. 2. 1. 6. |
Anti-double-stranded DNA antibodies (ds-DNA) |
assay |
4.37 |
11.59 |
15.96 |
||
|
7.19. 2. 1. 7. |
Anti-nuclear antibodies (ANA) |
assay |
4.37 |
11.59 |
15.96 |
||
|
7.19. 2. 1. 8. |
assay |
4.37 |
11.59 |
15.96 |
|||
|
7.19. 2. 1. 9. |
assay |
4.37 |
14.21 |
18.58 |
|||
|
7.19. 2. 1.10 |
Antimitochondrial antibodies (АМА) |
assay |
4.37 |
11.59 |
15.96 |
||
|
7.19. 2. 1.11 |
Anti-tissue transglutaminase antibodies (Ig А) |
assay |
4.37 |
9.99 |
14.36 |
||
|
7.19. 2. 1.12 |
Anti-tissue transglutaminase antibodies (Ig G) |
assay |
4.37 |
11.56 |
15.93 |
||
|
7.19. 2. 1.13. |
Anti- mutated citrullinated vimentin antibodies (MCV) |
assay |
4.37 |
16.68 |
21.05 |
||
|
7.19. 2. 1.14. |
Rheumatoid factor (Ig M) |
assay |
4.37 |
11.57 |
15.94 |
||
|
7.19. 2. 1.15 |
assay |
4.37 |
11.54 |
15.91 |
|||
|
7.19. 2. 1.16 |
Anti-proteinase 3 antibodies (PR-3) |
assay |
4.37 |
13.10 |
17.47 |
||
|
7.19. 2. 1.17. |
Anti-intrinsic factor antibodies (Castle factor) |
assay |
4.37 |
12.23 |
16.60 |
||
|
7.19. 2. 1.18. |
Anti-gliadin antibodies (IgA) |
assay |
4.37 |
11.54 |
15.91 |
||
|
7.19. 2. 1.19. |
Anti-gliadin antibodies (IgG) |
assay |
4.37 |
11.54 |
15.91 |
||
|
7.19. 2. 1.20. |
Anti-Saccharomyces cerevisiae antibodies (ASCA Ig A) |
assay |
4.37 |
11.54 |
15.91 |
||
|
7.19. 2. 1.21. |
Anti-Saccharomyces cerevisiae antibodies (ASCA Ig G) |
assay |
4.37 |
11.54 |
15.91 |
||
|
7.19. 2. 1.22. |
Screening of total antiphospholipid antibodies (cardiolipin, β2-glycoprotein 1, phosphatidylinositol, phosphatidylserine), class M (anti-Phospholipid Screen IgM) |
assay |
4.37 |
11.54 |
15.91 |
||
|
7.19. 2. 1.23. |
Screening of total antiphospholipid antibodies (cardiolipin, β2-glycoprotein 1, phosphatidylinositol, phosphatidylserine), class G (anti-Phospholipid Screen IgG) |
assay |
4.37 |
11.57 |
15.94 |
||
|
7.19. 2. 1.24. |
Phosphatidylserine M antibodies (IgM) |
assay |
4.37 |
11.35 |
15.72 |
||
|
7.19. 2. 1.25. |
Phosphatidylserine G antibodies (IgG) |
assay |
4.37 |
11.35 |
15.72 |
||
|
7.19. 2. 1.26. |
Lactoferrin antibodies |
assay |
4.37 |
9.46 |
13.83 |
||
|
7.19. 2. 1.27. |
Antibodies to soluble liver antigen (anti-SLA) |
assay |
4.37 |
14.73 |
19.10 |
||
|
7.19. 2. 1.28. |
Anti-liver kidney microsomal antibodies (anti-LKM-1) |
assay |
4.37 |
14.51 |
18.88 |
||
|
7.19. 2. 1.29. |
Deamidated gliadin peptide antibodies IgA (anti-DGP IgA) |
assay |
4.37 |
11.35 |
15.72 |
||
|
7.19. 2. 1.30. |
Deamidated gliadin peptide antibodies IgG (anti-DGP IgG) |
assay |
4.37 |
11.35 |
15.72 |
||
|
7.19. 2. 1.31. |
Anti-parietal cell antibodies IgG (anti-Parietal Cell IgG) |
assay |
4.37 |
11.54 |
15.91 |
||
|
7.19. 2. 1.32. |
Anti-glomerular basement membrane antibodies IgG (anti-GBM IgG) |
assay |
4.37 |
13.28 |
17.65 |
||
|
7.19. 2. 1.33. |
ANA antibodies (qualitative), immunoblotting, 9 parameters |
assay |
4.37 |
32.00 |
36.37 |
||
|
7.19. 2. 1.34. |
Antibodies (qualitative assay)-myo inositol profile-immunoblotting |
assay |
4.37 |
32.00 |
36.37 |
||
|
7.19. 2. 1.35. |
ANCA antibodies (qualitative assay), immunoblotting, 3 parameters |
assay |
4.37 |
32.00 |
36.37 |
||
|
7.19. 2. 1.36. |
Vitamin D2/D3-OH |
assay |
4.37 |
23.45 |
27.82 |
||
|
7.21. 2. |
Rheumatoid factor in serum (latex test) |
assay |
1.68 |
0.89 |
2.57 |
||
|
8. |
Bacteriological tests |
||||||
|
8. 3. 1. |
Microscopic examination of native preparations stained according to Gram: sputum, epithelial lining fluid, transudates, exudates (examination for aerobes and facultative anaerobes) |
examination |
12.71 |
0.24 |
12.95 |
||
|
8.17. 9. 1. 1. |
Helicobacter pylori antibodies in stool (viral and bacterial antigens ELISA, semi-automated calculation) |
assay |
12.41 |
5.19 |
17.60 |
||
|
8.17. 9. 1. 2. |
Helicobacter pylori antibodies in blood (viral and bacterial antigens ELISA, semi-automated calculation) |
assay |
12.41 |
2.88 |
15.29 |
||
|
8.17. 9. 1. 3. |
Varicella Zoster antibodies (IgG) (viral and bacterial antigens ELISA, semi-automated calculation) |
assay |
12.41 |
5.21 |
17.62 |
||
|
8.17. 9. 1. 4. |
IgM Toxoplasma |
assay |
12.41 |
6.01 |
18.42 |
||
|
8.17. 9. 1. 5. |
IgG Toxoplasma |
assay |
12.41 |
5.42 |
17.83 |
||
|
8.17. 9. 1. 6. |
IgM Cytomegalovirus (IgM CMV) |
assay |
12.41 |
5.24 |
17.65 |
||
|
8.17. 9. 1. 7. |
IgG Cytomegalovirus (IgG CMV) |
assay |
12.41 |
5.28 |
17.69 |
||
|
8.17. 9. 1. 8. |
Epstein–Barr virus early viral-capsid antigen IgG (EBV VCA/EA IgG) |
assay |
12.41 |
9.44 |
21.85 |
||
|
8.17. 9. 1. 9. |
Epstein–Barr virus viral-capsid antigen IgM (EBV VCA IgM) |
assay |
12.41 |
9.44 |
21.85 |
||
|
8.17. 9. 1.10. |
Epstein–Barr virus nuclear antigen IgG (EBV EBNA IgG) |
assay |
12.41 |
4.48 |
16.89 |
||
|
8.17. 9. 1.11. |
Screening test for syphilis (RPR-carbon) |
assay |
12.41 |
0.25 |
12.66 |
||
|
8.17. 9. 1.12. |
Hepatitis C antibodies (IgG) (Anti-HCV) |
assay |
12.41 |
4.58 |
16.99 |
||
|
8.17. 9. 1.13. |
Hepatitis B surface antigen (HBs Ag Ultra) |
assay |
12.41 |
4.39 |
16.80 |
||
|
8.17. 9. 1.14 |
IgM Rubella |
assay |
12.41 |
6.30 |
18.71 |
||
|
8.17. 9. 1.15 |
IgG Rubella |
assay |
12.41 |
5.33 |
17.74 |
||
|
8.17. 9. 1.16 |
Antibodies to herpes simplex virus 1 and 2 (IgМ) |
assay |
12.41 |
17.03 |
29.44 |
||
|
8.17. 9. 1.17 |
Antibodies to herpes simplex virus 1 and 2 (IgG) |
assay |
12.41 |
13.56 |
25.97 |
||
|
8.17. 9. 1.18. |
Cytomegalovirus IgG avidity |
assay |
12.41 |
12.70 |
25.11 |
||
|
8.17. 9. 1.19 |
Toxoplasma IgG avidity |
assay |
12.41 |
11.87 |
24.28 |
||
|
8.17. 9. 1.20 |
Antibodies to Chlamydia pneumoniae in serum (IgG) |
assay |
12.41 |
15.27 |
27.68 |
||
|
8.17. 9. 1.21 |
Antibodies to mycoplasma (IgА) |
assay |
12.41 |
13.53 |
25.94 |
||
|
8.17. 9. 1.22 |
Antibodies to mycoplasma pneumoniae in serum (IgM with absorption) |
assay |
12.41 |
16.23 |
28.64 |
||
|
8.17. 9. 1.23 |
Antibodies to mycoplasma pneumoniae in serum (IgG) |
assay |
12.41 |
13.52 |
25.93 |
||
|
8.17. 9. 1.24 |
Antibodies to Chlamydia pneumoniae in serum (IgA) |
assay |
12.41 |
18.41 |
30.82 |
||
|
8.17. 9. 1.25 |
Antibodies to Chlamydia pneumoniae in serum (IgM with absorption) |
assay |
12.41 |
18.75 |
31.16 |
||
|
8.17. 9. 4. 1. |
Immunoglobulins (antibodies) of one class to Chlamydia trachomatis ( IgG) + manual calculation of positivity coefficient and antibody titer |
assay |
13.12 |
13.45 |
26.57 |
||
|
8.17. 9. 4. 2. |
Immunoglobulins (antibodies) of one class to Chlamydia trachomatis ( IgA) + manual calculation of positivity coefficient and antibody titer |
assay |
13.12 |
13.43 |
26.55 |
||
|
8.17. 9. 4. 3. |
Immunoglobulins (antibodies) of one class to Chlamydia trachomatis (IgМ) (with RF absorbent) |
assay |
13.12 |
15.72 |
28.84 |
||
|
9. |
Genetic tests |
||||||
|
9. 7. |
Glucose tolerance test (double) |
test |
1.68 |
1.36 |
3.04 |
||
|
|
Admission Department of Therapy |
||||||
|
|
Pipetting |
||||||
|
1. 2.+ 1. 4. |
Registration + venous blood sampling for complete blood count, blood chemistry |
test |
4.97 |
1.00 |
5.97 |
||
